Safilo Group SpASAFLF 63 Receivables Turnover is 2.21 as of Dec. 2025. GuruFocus rates SAFLF with a GF Score™ of 63/100 and a GF Value™ of $1.22 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Safilo Group SpA ranks worse than 63.01% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Safilo Group SpA's Revenue for the
six
months ended in Dec. 2025 was $522 Mil. Safilo Group SpA's average Accounts Receivable for the
six
months ended in Dec. 2025 was $236 Mil.
Hence, Safilo Group SpA's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.21.
Safilo Group SpA (OTCPK:SAFLF) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Safilo Group SpA Receivables Turnover Related Terms
Safilo Group SpA Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Safilo Group SpA's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAFLF vs ISRG, BDX, MDLN: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Safilo Group SpA's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Safilo Group SpA Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Safilo Group SpA's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Safilo Group SpA's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Safilo Group SpA (SAFLF) has a Receivables Turnover of 2.21 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Safilo Group SpA and its competitors. According to the industry distribution chart, Safilo Group SpA ranks #511 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 63%.
Is Safilo Group SpA's Receivables Turnover too high?
Safilo Group SpA's current Receivables Turnover is 2.21. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Safilo Group SpA's value of 2.21 is 59.9% below this industry median. Based on the distribution chart, Safilo Group SpA ranks #511 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Safilo Group SpA has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Safilo Group SpA's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Safilo Group SpA ranks #511 out of 811 companies for Receivables Turnover. This places Safilo Group SpA in the lower half of its industry. The industry median Receivables Turnover is 5.51. Safilo Group SpA's value of 2.21 is 59.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Safilo Group SpA's current Receivables Turnover of 2.21 is 59.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Safilo Group SpA and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Safilo Group SpA's current Receivables Turnover is 2.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Safilo Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Safilo Group SpA (SAFLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.22, compared to a current price of $2.01 — trading 64.8% above its estimated fair value. The current Receivables Turnover is 2.21 and 59.9% below the Medical Devices & Instruments industry median of 5.51. Safilo Group SpA's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Safilo Group SpA (SAFLF), the current Receivables Turnover is 2.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Safilo Group SpA (SAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Safilo Group SpA stock appears to be overvalued.
The current stock price of $2.01 is trading 64.8% above its estimated GF Value™ of $1.22.
GuruFocus considers Safilo Group SpA to be Significantly Overvalued.
Key valuation signals for SAFLF:
Receivables Turnover: 2.21
GF Value™: $1.22 vs. price of $2.01 (64.8% above fair value)
Industry Position: 59.9% below the Medical Devices & Instruments median (#511 of 811)
No single metric tells the full story. See the SAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Safilo Group SpA makes sunglasses and prescription eyewear. It is engaged in design, production, and wholesale distribution of its products through a network of independent distributors and commercial subsidiaries. Its products are sold through the Carrera, Smith, Polaroid and Oxydo brands, as well as a range of other licensed brands. The company operates solely through the wholesale segment channels and divides itself into the following four geographical segments: Europe, America, and Asia. The company earns the majority of its revenue from the Europe business segment.
63GF Score
Get the complete analysis for SAFLF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAFLF has been successfully added to your 
